Concentration-Dependent Atypical Intestinal Absorption of Cyclic Phenylalanylserine: Small Intestine Acts as an Interface between the Body and Ingested Compounds(Biopharmacy)
スポンサーリンク
概要
- 論文の詳細を見る
Intestinal absorption of peptides in linear form has been studied extensively, but there is little knowledge of peptides in a cyclic form. In this report, intestinal absorption of cyclic phenylalanylserine (cyclo(Phe-Ser)), a precursor of gliotoxin, was studied in isolated rat small intestine as a model cyclic dipeptide. Absorption clearance (CLabs) decreased in the presence of glycylsarcosine, cephalexin or cephradine, substrates for H^+/oligopeptide cotransporter (PEPT1). CLabs of cyclo(Phe-Ser) also decreased at 4℃, thus indicating that cyclo(Phe-Ser) is in part transported by PEPT1. However, the Eadie-Hofstee plot of absorption revealed an atypical profile at lower concentrations of cyclo(Phe-Ser) (around 0.1 mM). Moreover, comparative experiments of absorptive and excretive transport showed that excretive transport from the serosal to mucosal side of isolated intestinal tissue at a 0.1 mM cyclo(Phe-Ser) was superior to absorptive transport from the mucosal side to the serosal side, and vice versa at a 1 mM cyclo(Phe-Ser). A kinetic model was constructed, in which cyclo(Phe-Ser) concentration for excretive transport was assumed to be at the binding site of excretive transporter, but not the unbound cytoplasmic concentration. These results as well as the results of kinetic analysis indicate that intestinal absorption consists of passive transport, carrier-mediated absorptive transport by PEPT1 and carrier-mediated excretive transport, resulting in atypical absorption. Although cyclic dipeptides have potentials as drugs, their intestinal absorption may be complex. The results of this study lead us to conclude that absorptive and excretive transport by the small intestine acts as an interface between the body and ingested compounds.
- 2003-11-01
著者
-
Awazu Shoji
Department Of Biopharmaceutics And Drug Rationale Research Center School Of Pharmacy Tokyo Universit
-
Mizuma T
Department Of Biopharmaceutics And Drug Rationale Research Center School Of Pharmacy Tokyo Universit
-
Mizuma Takashi
Department Of Biopharmaceutics And Drug Rational Research Center School Of Pharmacy Tokyo University
-
Awazu Shoji
Deparment Of Biopharmaceutics Tokyo College Of Pharmacy
-
NARASAKA Takuo
Department of Biopharmaceutics and Drug Rationale Research Center, School of Pharmacy, Tokyo Univers
-
Narasaka T
Department Of Biopharmaceutics And Drug Rationale Research Center School Of Pharmacy Tokyo Universit
-
Mizuma Takashi
Department of Applied Chemistry, Faculty of Engineering, Osaka University
関連論文
- HISTOPATHOLOGICAL STUDY OF THE EFFECTS OF A SINGLE INTRATRACHEAL INSTILLATION OF SURFACE ACTIVE AGENTS ON LUNG IN RATS
- IMPROVEMENT OF POORLY ABSORBABLE DRUG BY INTESTINAL GLUCOSE TRANSPORT SYSTEM
- Electrophysiological Evaluation for Conditions of Preservation of Isolated Human Colon Tissues
- Polarized Transport was Obseved not in Hydrophilic Compounds but in Dextran in Caco-2 Cell Monolayers
- PARACELLULAR CHANNEL CHARACTERIZED BY NON-ELECTROLYTE PERMEATION THROUGH THE COLONIC MEMBRANE OF THE RAT
- MECHANISMS FOR THE ENHANCEMENT OF INTESTINAL MEMBRANE PERMEABILITY BY ABSORPTION PROMOTERS
- ALTERATION IN RAT LIVER MICROSOMAL MEMBRANES INDUCED BY ACETAMINOPHEN
- HETEROGENEOUS DISTRIBUTION OF THE CONJUGATION ACTIVITY OF ACETAMINOPHEN AND p-NITROPHENOL IN ISOLATED RAT LIVER CELLS
- MULTIPLE FORMS OF ARYL SULFOTRANSFERASE FOR ACETAMINOPHEN SULFATE CONJUGATION IN RAT LIVER CYTOSOL
- HETEROGENEOUS DISTRIBUTION OF CONJUGATION ACTIVITIES OF HARMOL IN ISOLATED RAT LIVER CELLS
- Transport and Recognition of Aminopeptidase-Resistant Cellobiose-Coupled Tyrosylglycylglycine by Intestinal Na^+/Glucose Cotransporter (SGLT1) : Recognition of Suger Conjugates by SGLT1 Is Much Less Restricted than Transport
- Kinetic Impact of presystemic Intestinal Metabolism on Drug Absorption:Experiment and Date Analysis for the Prediction of In Vivo Absorption from In Vitro Data
- Preference of Peyer's Patches to Jejunal Epithelium for Intestinal Absorption of Oligopeptides, Tyrosylglycylglycine and D-Kyotorphin
- ACTION MECHANISM OF PERMEATION ENHANCERS IN PARACELLULAR PATHWAY
- Photo-Stability of Drugs in Enteral Hyperalimentation Solutions and Its Influence on the Dose Given by a Continuous Infusion
- INTESTINAL ABSORPTION OF MACROMOLECULAR COMPOUNDS-IS ITS IMPROVEMENT POSSIBLE?
- Evaluation of Dose of Unstable Drug Administered by Infusion
- ARYL SULFOTRANSFERASE IN RAT LIVER : MULTIPLICITY AND SUBSTRATE SPECIFICITY
- ALBUMIN-MEDIATED UPTAKE MECHANISM OF DRUG BY ISOLATED HEPATOCYTES
- CHARACTERIZATION OF THE INTERACTION OF ALBUMIN WITH ISOLATED RAT LIVER CELLS TO REVEAL THE MECHANISM OF ALBUMIN-MEDIATED HEPATIC TRANSPORT
- THE EFFECT OF ALBUMIN ON THE UPTAKE OF BROMOSULFOPHTHALEIN BY ISOLATED RAT HEPATOCYTES
- p-NITROPHENOL SULFATION IN RAT LIVER CYTOSOL : MULTIPLE FORMS AND SUBSTRATE INHIBITION OF ARYL SULFOTRANSFERASE
- CORRELATION OF DRUG CONJUGATIVE METABOLISM RATES BETWEEN IN VIVO AND IN VITRO : GLUCURONIDATION AND SULFATION OF p-NITROPHENOL AS A MODEL COMPOUND IN RAT
- Critical Factor in Intestinal Absorption of Peptide Drugs : Quantitative Analysis of Peptide Drug Absorption which is Competitive Process of Metabolism and Transport
- CORRELATION BETWEEN IN VIVO AND IN VITRO DRUG CONJUGATIVE METABOLISM RATE : p-NITROPHENOL AS A MODEL COMPOUND
- The Effects of Absorption Enhancers on the Pulmonary Absorption of Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) in Rats
- Effect of 2-Methylimidazole on the Mechanical, Biochemical, and Morphological Properties of the Rat Aorta by Its Chronic Treatment along Maturation
- Retention Mechanism of Imidazoles in Connective Tissue. IV. Identification of a Nucleophilic imidazolone Metabolite in Rats
- Retention Mechanism of Imidazoles in Connective Tissue. III. Aldehyde Adduct Formation of a 4(5H)(or 5(4H))-Imidazolone Product in Vitro
- Retention Mechanism of Imidazoles in Connective Tissue. II. Activation of Imidazoles in Cupro-ascorbate System for Irreversible Binding Formation with Aortic Tissue in Vitro
- Report 1 : OUTLINE AND DISCUSSION POINTS OF GUIDANCE FOR REPEATED DOSE TISSUE DISTRIBUTION STUDIES (Repeated dose tissue distribution studies)
- Pulmonary Absorption of Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) after Intratracheal Administration to Rats
- Hepatic Uptake of Lipid-Soluble Drugs from Fat Emulsion
- Paracellular and Transcellular Permeabilities of Fosfomycin across Small Intestinal Membrane of Rat and Rabbit by Voltage-Clamp Method
- ADM-INDUCED LIPID PEROXIDATION IN RAT LIVER AND HEART
- PROTECTION OF RAT SMALL INTESTINE BY VITAMIN A FROM METHOTREXATE-INDUCED DAMAGE : STUDY ON THE NUTRIENT ABSORPTION IN THE SMALL INTESTINE
- Effect of Carrier-Mediated Transport System on Intestinal Fosfomycin Absorption in Situ and in Vivo
- PROTECTION OF RAT SMALL INTESTINE BY VITAMIN A FROM ITS DAMAGE INDUCED BY METHOTREXATE
- SOLVENT DRAG EFFECT IN DRUG INTESTINAL ABSORPTION : STUDIES ON DRUG AND D_2O ABSORPTION CLEARANCES
- High-performance liquid chromatographic determination and identification of acyl migration and photodegradation products of furosemide 1-O-acyl glucuronide
- IRREVERSIBLE BINDING OF FUROSEMIDE TO HUMAN SERUM ALBUMIN BY METABOLIC ACTIVATION, PHOTOACTIVATION AND BOTH ACTIVATIONS
- IMPROVEMENT OF BIOAVAILABILITY OF POORLY ABSORBED DRUGS. V. EFFECT OF SURFACTANTS ON THE PROMOTING EFFECT OF MEDIUM CHAIN GLYCERIDE FOR THE RECTAL ABSORPTION OF β-LACTAM ANTIBIOTICS IN RATS AND DOGS
- IMPROVEMENT OF BIOAVAILABILITY OF POORLY ABSORBED DRUGS. IV. MECHANISM OF THE PROMOTING EFFECT OF MEDIUM CHAIN GLYCERIDE ON THE RECTAL ABSORPTION OF WATER SOLUBLE DRUGS
- IMPROVEMENT OF BIOAVAILABILITY OF POORLY ABSORBED DRUGS. III. ORAL ACUTE TOXICITY AND LOCAL IRRITATION OF MEDIUM CHAIN GLYCERIDE
- IMPROVEMENT OF BIOAVAILABILITY OF POORLY ABSORBED DRUGS. II. EFFECT OF MEDIUM CHAIN GLYCERIDE BASE ON THE INTESTINAL ABSORPTION OF CEFMETAZOLE SODIUM IN RATS AND DOGS
- IMPROVEMENT OF BIOAVAILABILITY OF POORLY ABSORBED DRUGS.I.EFFECT OF MEDIUM CHAIN GLYCERIDE BASE ON THE RECTAL ABSORPTION OF CEFMETAZOLE SODIUM IN RATS
- Concentration-Dependent Atypical Intestinal Absorption of Cyclic Phenylalanylserine: Small Intestine Acts as an Interface between the Body and Ingested Compounds(Biopharmacy)
- Factors Affecting Glucuronidation Activity in Caco-2 Cells
- FACTORS IN BLOOD SIDE INFLUENCING INTESTINAL DRUG ABSORPTION AND METABOLISM
- CHARACTERIZATION OF FLUORESCENT SUBSTANCES IN PEROXIDIZED RAT LIVER MICROSOMAL MEMBRANE
- FLUORESCENT PRODUCTS AND MEMBRANE FLUIDITY IN PEROXIDIZED RAT LIVER MICROSOMES
- DRUG ABSORPTION MECHANISM BY PROMOTERS IN PARACELLULAR AND TRANSCELLULAR ROUTES
- PROMOTING MECHANISM BY BILE SALT RELATED TO WATER ABSORPTION IN DRUG RECTAL ABSORPTION
- PROTEIN FOR DRUG DISTRIBUTION IN MUSCLE
- DISTRIBUTION AND BINDING OF DRUGS TO MUSCLE TISSUES IN RAT
- SOLVENT DRAG IN JEJUNAL ABSORPTION OF SALICYLIC ACID AND ANTIPYRINE OBTAINED BY IN SITU SINGLE-PASS RERFUSION METHOD IN RAT
- DRUG DISTRIBUTION AND BINDING TO MUSCLE IN RAT
- SOLVENT DRAG EFFECT IN DRUG INTESTINAL ABSORPTION. I. STUDIES ON DRUG AND D_2O ABSORPTION CLEARANCES
- Molecular structures of (2)(2,5)(7,7,8,8-tetracyanoquinodimethano)(2)paracyclophane and 14,17-dimethoxy(2)(2,5)(7,7,8,8-tetracyanoquinodimethano)(2)paracyclophane.
- The crystal structure of 2,11,20-trithia(3.3.3)(1,2,4)(1,3,5)cyclophane and molecular structures of unsymmertically tris-bridged (2.2.2)(1,2,4)(1,3,5) and (2.2.2)(1,2,4)(1,2,5)cyclophanes, estimated by molecular conformational analysis.
- Molecular structure of (2)(2,5)(7,7,8,8-tetracyanoquinodimethano)-(2)(1,4)naphtalenophane.